-
Mashup Score: 0Practice Question of the Week - IAS-USA - 3 year(s) ago
After failing a regimen of tenofovir disoproxil fumarate (TDF)/lamivudine/efavirenz that resulted in resistance mutations in the nucleos(t)ide components, which of these regimens has been shown to be least effective? Responses A. Boosted darunavir with zidovudine/lamivudine 15% (120) B. Boosted darunavir with TDF/lamivudine 14% (108) C. Dolutegravir with zidovudine/lamivudine 10%…
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet
-
Mashup Score: 2The 2022 IAS-USA Guidelines Virtual Update: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults - 3 year(s) ago
Last Modified: Dec 12, 2022 @ 3:35 PM Program Description This course will review the newly released Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society–USA Panel, published online by JAMA on December 1, 2022. This course will cover the key changes and updates through a novel series of presentations and…
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet-
This Thurs! Join us! 🔥off the press: 2022 IAS-USA #HIV ART Guidelines Webinar @RMKGandhi @msaagmd @CarlosdelRio7 @SandySpringerMD @DrEllenEaton https://t.co/mteQeChGPs
-
-
Mashup Score: 1The 2022 IAS-USA Guidelines Virtual Update: Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults - 3 year(s) ago
Last Modified: Dec 12, 2022 @ 3:35 PM Program Description This course will review the newly released Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society–USA Panel, published online by JAMA on December 1, 2022. This course will cover the key changes and updates through a novel series of presentations and…
Source: IAS-USACategories: Infectious Disease, Latest HeadlinesTweet-
Join the @IAS_USA webinar Dec 15 (1 - 5 PM ET) where we will discuss the recent paper published in @JAMA_current with current updates on HIV treatment and prevention. Speakers include @RMKGandhi @drmt @DrEllenEaton @jmmolinaparis and others. Register at https://t.co/abV4zNEyHi
-
-
Mashup Score: 0Practice Question of the Week - IAS-USA - 3 year(s) ago
A patient presents with cryptococcal meningitis, severe headache, and opening pressure greater than 25 cm H20 on day 1 of therapy. Which of the following would you initiate if the central nervous system (CNS) symptoms persist on day 2? Responses A. Dexamethasone 18% (62) B. Acetazolamide 4% (13) C. Mannitol 7% (24) D. Lumbar puncture to remove fluid 53% (179) E. Lumbar puncture for…
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet-
The Practice Question of the Week from IAS-USA is now available. To view the response options, provide your answer, and get additional information on this topic, please visit: https://t.co/DUFwGCClj2 https://t.co/KQXRAjwX26
-
-
Mashup Score: 0Donate - IAS-USA - 3 year(s) ago
Please support the IAS–USA in its efforts to deliver continuing education and crucial information to health care practitioners who provide care for people with HIV and AIDS. Your donation will be used to help supply clinicians all around the globe with the best science and effective practices for their vital work. Resources such as the […]
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet-
World AIDS Day is a time to bring attention to ongoing endeavors to treat these viruses and their related conditions. To find out information on how to donate, please visit: https://t.co/suDdhRpQhS https://t.co/FTV8N4Wz9K
-
-
Mashup Score: 0Practice Question of the Week - IAS-USA - 3 year(s) ago
Treatment of monkeypox virus infection can include various options for therapy. To recover, most individuals will need which of the following? Responses A. Tecovirimat 26% (160) B. Supportive care 61% (386) C. JYNNEOS vaccine 8% (49) D. Brincidofovir 5% (34) A. Immediately B. In the next 2 weeksC. After completing 21 days of trimethoprim-sulfamethoxazolD. At her…
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet-
The Practice Question of the Week from IAS-USA is now available. To view the response options, provide your answer, and get additional information on this topic, please visit: https://t.co/DUFwGCTol2 https://t.co/LgG0hqOcBf
-
-
Mashup Score: 0Physical Education: Bridging Clinical Research and Patient Care - 3 year(s) ago
The mission of the IAS–USA is to improve the prevention, treatment, care, and quality of life for people with or at risk of HIV, hepatitis C virus, or other viral infections through high-quality, relevant, balanced, and needs-oriented education and information for practitioners and scientists who are actively involved in medical care and research.
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet-
During this holiday, IAS-USA wants to express our gratitude to our faculty for their support and contributions to our vibrant selection of activities in 2022. Updates on courses and conferences for the remainder of the year are available at https://t.co/IFDWaIwi8z. https://t.co/Y8oUgVNMuf
-
-
Mashup Score: 0Basics of HIV Drug Resistance Mutations - 3 year(s) ago
Assessment of Needs This webinar will provide a basic review of HIV drug resistance mutations, including a review of the recent IAS–USA 2022 Update of the Drug Resistance Mutations in HIV-1. Learning Objectives At the end of this webinar, participants will be able to: Describe basic principles of HIV drug resistance mutations Explain how to identify HIV drug resistance in…
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet-
Rescheduled webinar: Register for our postponed October 27, 2022 webinar "Basics of HIV Drug Resistance Mutations" to be presented by Dr. Francesca Ceccherini Silberstein, Dr. Douglas D. Richman, and Dr. Robert W. Shafer, on December 14, 2022 ➡️ https://t.co/QyiFVnn1np https://t.co/hXlOKyPJmQ
-
-
Mashup Score: 0Addressing Challenges in Alzheimer’s Disease in People With HIV - 3 year(s) ago
Assessment of Needs Increasingly, clinical populations of people with HIV are in age ranges that increase their risk for Alzheimer’s disease and related dementia syndromes. Clinicians treating HIV will receive a higher number of queries from patients around these age-associated diseases. This webinar aims to describe gaps in our understanding of the intersection of HIV and Alzheimer’s disease and…
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet-
Registration is now open for our upcoming webinar "Addressing Challenges in Alzheimer’s Disease in People With HIV" to be presented by @victorvalcour on January 10, 2023 ➡️ https://t.co/Buo81fhusT https://t.co/78HqrTgSuf
-
-
Mashup Score: 0Breast/Chestfeeding Among Individuals With HIV: Where Have We Been and Where Are We Going? - 3 year(s) ago
Assessment of Needs This presentation will review what is known about HIV transmission via breast milk, why recommendations for and against breastfeeding vary among low- and high-resource countries, and how US guidelines are changing. Learning Objectives Upon completion of this activity, learners will be able to: State what is known about the risk of HIV transmission via breast milk with and…
Source: IAS-USACategories: HIV/AIDS, Latest HeadlinesTweet-
Registration is now open for our upcoming webinar "Breast/Chestfeeding Among Individuals With HIV: Where Have We Been and Where Are We Going?" to be presented by Dr. Judy Levison on January 17, 2023 ➡️ https://t.co/07duduLBV1 https://t.co/AhZkydbI8s
-
The Practice Question of the Week from IAS-USA is now available. To view the response options, provide your answer, and get additional information on this topic, please visit: https://t.co/4SQ9k55KsT https://t.co/fXOshxYuCR